Keyphrases
Cancer Therapy
100%
Diarrhea
100%
Meta-analysis
100%
Confidence Interval
42%
Relative Risk
42%
Placebo
14%
Randomized Controlled Trial
14%
Cancer Prevention
14%
PubMed
14%
Preclinical Data
14%
Tyrosine Kinase Inhibitor
14%
Embase
14%
Common Terminology Criteria for Adverse Events (CTCAE)
14%
Preventive Strategies
14%
Gastrointestinal Toxicity
14%
Anticancer Therapy
14%
Search Strategy
14%
Protectins
14%
Cochrane Collaboration
14%
Cytotoxic Therapy
14%
CINAHL
14%
Rescue Medication
14%
Meta-analysis of Randomized Controlled Trials
14%
RevMan
14%
Microbial Phenotypes
14%
Probiotic Intervention
14%
Dacomitinib
14%
Three Step Search
14%
Medicine and Dentistry
Cancer Therapy
100%
Diarrhea
100%
Meta-Analysis
100%
Probiotics
100%
Randomized Controlled Trial
28%
Placebo
14%
Immunotherapy
14%
Cancer Treatment
14%
Gastrointestinal Toxicity
14%
Cytotoxic Chemotherapy
14%
Tyrosine-Kinase Inhibitor
14%
Dacomitinib
14%